• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>IMS Health

IMS Health

Cannabis Rx Inc CANA

Last Price$0.22Day Change (%)-17.70%
Open Price$0.22Day Change ($)-0.05
Day Range0.22–0.2752-Week Range0.13–7.20

As of Wed 09/17/2014 02:46 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Global Cell Culture Market Forecasts and Opportunities, 2018

    Research and Markets: Global Cell Culture Market Forecasts and Opportunities, 2018

  2. Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC

    Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC

  3. TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension

    TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension

  4. Mylan Launches First Generic Klor-Con® Extended-Release Tablets

    Mylan Launches First Generic Klor-Con® Extended-Release Tablets

  5. Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

    Mylan Launches Generic Precedex™ Injection - Another Key Product Approval

  6. Our Take on the Second Quarter

    Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.

  7. Trouble in Plain Sight

    IMS Health is on the right track for growth.

  8. Our Take on the Fourth Quarter

    A look back at the winners and losers of the final quarter of a tumultuous year.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.